Novo Holdings A/S’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History

Novo Holdings A/S’s Portfolio CMPI Stock Details CMPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,161,990	Closed	-$6.9M	–	57
2022 Q1	$6.9M	Sell	2,161,990 -8,110	-0.4%	-$23.3K	0.36%	41
2021 Q4	$6.23M	Hold	2,170,100	–	–	0.29%	43
2021 Q3	$8.62M	Hold	2,170,100	–	–	0.45%	32
2021 Q2	$12.9M	Hold	2,170,100	–	–	0.57%	31
2021 Q1	$26.3M	Hold	2,170,100	–	–	1.09%	20
2020 Q4	$31.7M	Hold	2,170,100	–	–	1.36%	18
2020 Q3	$25M	Buy	+2,170,100	New	+$27.8M	1.24%	16

Novo Holdings A/S's CMPI Position: Q2 2022 in Review

Novo Holdings A/S sold out of Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) in Q2 2022, closing a stake of 2,161,990 shares — an estimated $6.9M sold.

Novo Holdings A/S first reported a position in CMPI in Q3 2020 and held it in 7 quarters. The position peaked at $31.7M in Q4 2020. 0 funds tracked by Wall St. Rank hold CMPI as of Q2 2022.

Novo Holdings A/S reported no remaining Checkmate Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Novo Holdings A/S sold 2,161,990 Checkmate Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $6.9M.
Novo Holdings A/S first reported a position in Checkmate Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Novo Holdings A/S's Checkmate Pharmaceuticals, Inc. Common Stock position peaked at $31.7M in Q4 2020.
0 funds tracked by Wall St. Rank held Checkmate Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Novo Holdings A/S's 13F filing for Q2 2022, filed 15 Aug 2022.